Letter to the editor RE: “Testing an experimental vaccine during a public health emergency: Lessons from a Peruvian case”

Abstract

Abstract: This letter to the editor responds to a previously published ethical analysis concerning the implementation of a COVID-19 vaccine trial in Peru during the public health emergency. The author contextualizes the events surrounding the trial by describing the involvement of Peruvian governmental institutions, foreign authorities, and research universities, as well as the extraordinary circumstances under which the study was conducted. The letter argues that the ethical and regulatory irregularities must be understood within the pressures of the pandemic, institutional limitations, and the ambiguous status of experimental vaccines at the time. While acknowledging procedural breaches and governance failures, the author emphasizes that participant safety and study integrity were ultimately preserved, and details the corrective actions undertaken by the university, including international audits, restructuring of the research team, reinforcement of oversight mechanisms, and development of a stronger regulatory framework for future clinical trials. The article concludes that the crisis served as an opportunity for institutional learning, ethical reflection, and long-term improvement in research governance.